News | SPECT-CT | October 18, 2022

Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine

Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine

October 18, 2022 —  Spectrum Dynamics announced its newest development in digital nuclear medicine imaging: the capability to image high energy isotopes using solid-state detector technology in a 3600-CZT based, wide-bore SPECT/CT configuration. This functionality is available in the new VERITON-CT 400 Series Digital SPECT/CT scanners, enabling total body, brain, heart and other imaging applications. 

“This truly represents a transformation in how we will image high energy isotopes: with the sensitivity benefits of digital detector technology, advanced reconstruction algorithms and total body coverage in 3D, both patients and clinicians will benefit from this innovation”, said Nathaniel Roth, VP Research and Development and Clinical Research, Spectrum Dynamics. 

The VERITON-CT 400 Series features Spectrum Dynamics’ radical design, with its 3600 ring-shaped gantry with 12 swiveling CZT detectors, that revolutionized nuclear medicine imaging industry in 2017. During the scan, the digital detectors automatically follow the patient’s body contour, providing exceptional proximity for increased sensitivity and better image quality. This design results in three times the volumetric sensitivity for routine 3D hybrid imaging without compromising patients comfort or department workflow. The scanner is available in 16-slice CT and 64-slice CT configuration enabling localization and attenuation correction for accurate quantification. 

“The new VERITON-CT 400 has proved to be advantageous for high-energy tracers. In our nuclear medicine community, the main challenge now is to personalize and adapt targeted treatments to each individual. This requires precise determination of the distribution of delivered doses within the body. The scanner has the potential to do so with high quantitative accuracy and fast scan times to be used for a routine application”, said Prof. Pierre-Yves Marie, MD, Ph.D., Head Department of Nuclear Medicine, University Hospital of Nancy, France. 

For more information: https://spectrum-dynamics.com/ 

Find more ASTRO22 content here


Related Content

Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | SNMMI

September 18, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), as a professional society ...

Time September 18, 2023
arrow
News | Ultrasound Imaging

September 8, 2023 — When diagnosing and treating cancer patients, the dynamics of blood flow to and from a suspected ...

Time September 08, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 31, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time August 31, 2023
arrow
News | Radiation Therapy

August 30, 2023 — A published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children ...

Time August 30, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a ...

Time August 29, 2023
arrow
News | Radiation Therapy

August 23, 2023 — RefleXion Medical, a therapeutic oncology company, today announced that the first patient has ...

Time August 23, 2023
arrow
News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Time August 17, 2023
arrow
Subscribe Now